Relief Therapeutics Holding AG (RLFTF)

[Uncle Gee Gee]

I don't think they would do it until at least the first IV study comes back from the FDA... then they have serious leverage to negotiate and do valuations. But even then, they might hold out for the inhaler too.

Also, keep in mind that they've started a separate effort for the European market with a separate CMO and trials, so maybe they end up going a licensing route, rather than a total sale, where they license the rights out to 1 or several companies in each country.

But honestly, I'm no expert on mergers & acquisitions.